Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiation Raises Risk of Repeat Tumors in Children

By HospiMedica staff writers
Posted on 13 Nov 2006
Radiation exposure may increase the risk of brain and spinal column tumors in survivors of childhood cancer, according to new research.

Survivors of childhood cancer are at an increased risk for developing second cancers, but the risk of these cancers differs based on the original cancer, age, a first cancer diagnosis, and primary cancer therapy received. More...
Secondary tumors of the central nervous system (CNS) can have especially debilitating consequences and have been associated with earlier treatment for childhood leukemia and brain tumors, according to a study published in the November 1, 2006, issue of the Journal of the [U.S.] National Cancer Institute.

In the study, Joseph P. Neglia, M.D., a pediatric oncologist and researcher from the University of Minnesota Medical School and Cancer Center (Minneapolis, MN, USA) and colleagues identified secondary CNS tumors in a group of 14,361 5-year survivors of childhood cancer. They also gathered information regarding the patients' exposure to radiation and the chemotherapy used to treat the first cancer.

The investigators discovered that 116 survivors of childhood cancer developed subsequent CNS tumors. Childhood radiation exposure was linked with a higher risk of developing both malignant brain tumors like glioma and benign tumors like meningiomas. The risk of a second tumor increased as the dose of radiation used to treat the first cancer increased. Children under age five were particularly susceptible to the development of secondary gliomas. The scientists suggested that the increased tumor incidence in children exposed at an early age may indicate that the developing brain is very susceptible to radiation's toxic effects.

"Prolonged follow-up of all childhood cancer survivors, particularly those exposed to radiation, is crucial to the early detection of these tumors and should be considered part of the effective therapy of the primary disease,” the scientists wrote in their article.

In an accompanying editorial in the same issue, Elaine Ron, Ph.D., from the U.S. National Cancer Institute (NCI; Bethesda, MD, USA) stated, "By identifying persons at high risk of long-term treatment effects, it may be possible to reduce the growing number of patients who develop secondary malignancies by individualizing treatment.”



Related Links:
University of Minnesota Medical School and Cancer Center

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Radiofrequency Generator
GX1
New
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The device combines a minimally invasive, long‑lifetime “read/write” brain‑computer interface (BCI) with assistive devices and AI-driven support (photo courtesy of Epia Neuro)

Implantable Brain-Computer Interface Supports Stroke Recovery and Assistive Function

Stroke leaves many survivors with chronic motor deficits that limit independence, and cognitive decline is a growing concern in aging populations. Stroke is a leading cause of long-term disability in the... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.